Natural and designer binding sites made by phage display technology

Immunology Today

Volumn 21, Issue 8, 2000, Pages 371-378

  Hoogenboom, Hennie R ^a,b   Chames, Patrick ^b  

^a Dyax Corp   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY REACTION; ANTIGEN PURIFICATION; BINDING SITE; BIOENGINEERING; CONTROLLED STUDY; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE LIBRARY; GENOTYPE; HUMAN; HUMAN CELL; HYBRIDOMA; MOLECULAR CLONING; MOUSE; NONHUMAN; PHAGE DISPLAY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; TECHNOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIA; BINDING SITES, ANTIBODY; BIOTECHNOLOGY; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; PEPTIDE LIBRARY; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; RIBOSOMES; YEASTS;

EID: 0033853776     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(00)01667-4     Document Type: Review

References (80)

1. Man-made antibodies
2. Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains
3. Replacing the complementarity-determining regions in a human antibody with those from a mouse
4. Recombinant antibody fragments
5. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface
6. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction
7. Direct cDNA cloning of the rearranged immunoglobulin variable region
8. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli
9. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda
10. Escherichia coli secretion of an active chimeric antibody fragment
11. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli
12. Phage antibodies: Filamentous phage displaying antibody variable domains
13. Multi-subunit proteins on the surface of filamentous phage: Methodologies for displaying antibody (Fab) heavy and light chains
14. Fab assembly and enrichment in a monovalent phage display system
15. Expression of antibody Fab domains on bacteriophage surfaces
16. Phage diabody repertoires for selection of large numbers of bispecific antibody fragments
17. Making antibody fragments using phage display libraries
18. Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning
19. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic individuals
20. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum
21. Anti-melanoma antibodies from melanoma patients immunised with genetically modified autologous tumor cells: Selection of specific antibodies from single-chain Fv fusion phage libraries
22. By-passing immunization: Human antibodies from V-gene libraries displayed on phage
23. Semisynthetic combinatorial libraries: A chemical solution to the diversity problem
24. Making antibody by phage display technology
25. Antibody phage display technology and its applications
26. Antibody engineering
27. In vitro selection and evolution of functional proteins by using ribosome display
28. Display of heterologous proteins on the surface of microorganisms: From the screening of combinatorial libraries to live recombinant vaccines
29. Yeast surface display for screening combinatorial polypeptide libraries
30. Designing and optimizing library selection strategies for generating high-affinity antibodies
31. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies
32. Selection of phage-displayed Fab antibodies on the active conformation of Ras yields a high affinity conformation-specific antibody preventing the binding of c-Raf kinase to Ras
33. Direct selection of a human antibody fragment binding to the tumor T cell epitope HLA-A1/MAGE-A1 from a non immunized phage-Fab library
34. Pathfinder selection: In situ isolation of novel antibodies
35. Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library
36. Antibody scFv fragments without disulfide bonds made by molecular evolution
37. Proteolytic selection for protein folding using filamentous bacteriophages
38. Rescue of a neutralizing anti-viral antibody fragment from an intracellular polyclonal repertoire expressed in mammalian cells
39. Selectively infective phage (SIP) technology: Scope and limitations
40. Tapping the potential of molecular libraries in functional genomics
41. Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines
42. Protein microarrays for gene expression and antibody screening
43. A post-genomics challenge: Learning to read patterns of protein expression
44. Cell selection strategies for making antibodies from variable gene libraries: Trapping the memory pool
45. Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens
46. Human antibody with sub-nanomolar affinities isolated from a large non-immunized phage display library
47. Isolation of high affinity human antibodies directly from large synthetic repertoires
48. Exploiting recombination in single bacteria to make large phage antibody libraries
49. Diabodies: Small bispecific antibody fragments
50. High avidity scFv multimers; diabodies and triabodies
51. Somatic insertions and deletions shape the human antibody repertoire
52. Kinetic and affinity limits on antibodies produced during immune responses
53. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site
54. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range
55. Light chains shuffling of a high affinity antibody results in a drift in epitote recognition
56. By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro
57. Antibody fragments from a 'single pot' phage display library as immunochemical reagents
58. Selection of an anti-IGF-1 Fab from a Fab phage library created by mutagenesis of multiple CDR loops
59. Domain libraries: Synthetic diversity for de novo design of antibody V regions
60. Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel
61. Exploiting sequence space: Shuffling in vivo formed complementary determining regions into a master framework
62. Expanding the conformational diversity by random insertions to CDRH2 results in improved anti-estradiol antibodies
63. Towards the design of an antibody that recognises a given protein epitope
64. Gene technologies for antibody engineering
65. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides
66. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies
67. Single antibody domains as small recognition units: Design and in vitro antigen selection of camelized, human VH domains with improved protein stability
68. An antibody single-domain phage display library of a native heavy chain region: Isolation of functional single- domain VH molecules with a unique interface
69. Tendamistat as a scaffold for conformationally constrained phage peptide libraries
70. The fobronection type III domain as a scaffold for novel binding proteins
71. Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands
72. Scaffolds for engineering novel binding sites in proteins
73. Therapeutic monoclonal antibodies
74. Guiding the selection of human antibodies from phage display repetoires to single epitope of an antigen
75. Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library
76. Isolation of pricomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site
77. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma
78. Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment
79. Guided selection of a pan carcimona specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent
80. Antibody humanization using monovalent phage display